Establishment and Use of Patient-Derived Xenograft Models for Drug Testing in Head and Neck Squamous Cell Carcinoma

Summary: This protocol provides the steps required for the establishment of patient-derived xenograft (PDX) tumors for head and neck squamous cell carcinomas (HNSCCs) and their utility in examining drug responses. PDXs recapitulate the heterogeneity observed in the corresponding human tumors, which...

Full description

Bibliographic Details
Main Authors: Christina Karamboulas, Jalna Meens, Laurie Ailles
Format: Article
Language:English
Published: Elsevier 2020-06-01
Series:STAR Protocols
Online Access:http://www.sciencedirect.com/science/article/pii/S2666166720300113
_version_ 1818245024704364544
author Christina Karamboulas
Jalna Meens
Laurie Ailles
author_facet Christina Karamboulas
Jalna Meens
Laurie Ailles
author_sort Christina Karamboulas
collection DOAJ
description Summary: This protocol provides the steps required for the establishment of patient-derived xenograft (PDX) tumors for head and neck squamous cell carcinomas (HNSCCs) and their utility in examining drug responses. PDXs recapitulate the heterogeneity observed in the corresponding human tumors, which makes them an ideal pre-clinical model system. This protocol outlines the detailed steps required for (1) the generation of HNSCC-PDXs, (2) the processing of tumor tissues, and (3) the expansion of PDX models into cohorts for (4) drug testing.For complete details on the use and execution of this protocol please refer to Karamboulas et al. (2018).
first_indexed 2024-12-12T14:26:20Z
format Article
id doaj.art-59043720aec6428fadeb9e2e11a2bb49
institution Directory Open Access Journal
issn 2666-1667
language English
last_indexed 2024-12-12T14:26:20Z
publishDate 2020-06-01
publisher Elsevier
record_format Article
series STAR Protocols
spelling doaj.art-59043720aec6428fadeb9e2e11a2bb492022-12-22T00:21:40ZengElsevierSTAR Protocols2666-16672020-06-0111100024Establishment and Use of Patient-Derived Xenograft Models for Drug Testing in Head and Neck Squamous Cell CarcinomaChristina Karamboulas0Jalna Meens1Laurie Ailles2Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada; Corresponding authorPrincess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, CanadaPrincess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada; Department of Medical Biophysics, University of Toronto, Toronto, ON M5G 1L7, Canada; Corresponding authorSummary: This protocol provides the steps required for the establishment of patient-derived xenograft (PDX) tumors for head and neck squamous cell carcinomas (HNSCCs) and their utility in examining drug responses. PDXs recapitulate the heterogeneity observed in the corresponding human tumors, which makes them an ideal pre-clinical model system. This protocol outlines the detailed steps required for (1) the generation of HNSCC-PDXs, (2) the processing of tumor tissues, and (3) the expansion of PDX models into cohorts for (4) drug testing.For complete details on the use and execution of this protocol please refer to Karamboulas et al. (2018).http://www.sciencedirect.com/science/article/pii/S2666166720300113
spellingShingle Christina Karamboulas
Jalna Meens
Laurie Ailles
Establishment and Use of Patient-Derived Xenograft Models for Drug Testing in Head and Neck Squamous Cell Carcinoma
STAR Protocols
title Establishment and Use of Patient-Derived Xenograft Models for Drug Testing in Head and Neck Squamous Cell Carcinoma
title_full Establishment and Use of Patient-Derived Xenograft Models for Drug Testing in Head and Neck Squamous Cell Carcinoma
title_fullStr Establishment and Use of Patient-Derived Xenograft Models for Drug Testing in Head and Neck Squamous Cell Carcinoma
title_full_unstemmed Establishment and Use of Patient-Derived Xenograft Models for Drug Testing in Head and Neck Squamous Cell Carcinoma
title_short Establishment and Use of Patient-Derived Xenograft Models for Drug Testing in Head and Neck Squamous Cell Carcinoma
title_sort establishment and use of patient derived xenograft models for drug testing in head and neck squamous cell carcinoma
url http://www.sciencedirect.com/science/article/pii/S2666166720300113
work_keys_str_mv AT christinakaramboulas establishmentanduseofpatientderivedxenograftmodelsfordrugtestinginheadandnecksquamouscellcarcinoma
AT jalnameens establishmentanduseofpatientderivedxenograftmodelsfordrugtestinginheadandnecksquamouscellcarcinoma
AT laurieailles establishmentanduseofpatientderivedxenograftmodelsfordrugtestinginheadandnecksquamouscellcarcinoma